Core Viewpoint - Shenzhen Huatai Medical Instruments Co., Ltd. announced that its controlling shareholder, Shenzhen Mindray Technology Holdings Co., Ltd., increased its stake in the company by 655,536 shares, representing a 0.46% increase in ownership [1] Group 1: Shareholding Changes - Before the transaction, Mindray and its concerted party, Zhuhai Tongsheng Investment Partnership, held a total of 34,597,913 shares, accounting for 24.54% of the total share capital [1] - After the transaction, their combined holdings increased to 35,253,449 shares, representing 25.00% of the total share capital [1] - The increase in shareholding does not trigger a mandatory tender offer and will not change the controlling shareholder or actual controller of the company [1] Group 2: Transaction Details - The share increase was executed through a block trade on September 3, 2025, at a price of 248.20 yuan per share [1] - The total number of shares purchased was 655,536, resulting in an increase of 0.4649% in ownership [1] - The funds for this transaction were sourced entirely from Mindray's own or self-raised funds, with no involvement from the company or its affiliates [1] Group 3: Compliance and Reporting - The shares involved in this transaction are unrestricted circulating shares, which enjoy voting rights without any limitations [1] - The transaction complies with the relevant laws and regulations, including the Securities Law of the People's Republic of China and the Management Measures for the Acquisition of Listed Companies [1] - A detailed report on the equity change has been disclosed on the Shanghai Stock Exchange's website [1]
惠泰医疗: 关于股东权益变动的提示性公告